DUBLIN, November 17, 2017 /PRNewswire/ --

The "Label-Free Detection Market-Global Opportunity Analysis and Industry Forecast (2017-2022)" report has been added to Research and Markets' offering.

Global label free detection market is expected to reach USD 2,292.0 million by 2022, at a CAGR of 8.8% during the forecast period of 2017 to 2022.

The global label free detection market is mainly driven by rapid growth in pharmaceutical and biotechnology market, rising government initiatives and funding for various R&D activities, and increasing drug discovery with innovative approaches. Moreover, emerging economies such as Asia-Pacific and Latin America provides significant opportunities in this market.

Cells and organs are complex systems because of the interactions and the relations between cells to cells, DNA to RNA, RNA to proteins, and other biomolecules. In this, the Protein-Protein Interactions (PPIs) are one of the most significant, interesting, and complicated interactions due to their ability to bind together and form a complex in order to carry out biological functions.

The molecular and biological processes are largely dependent on these interactions and abnormal mechanisms in these lead to the development of various chronic diseases such as cancers and metabolic syndromes among others. Therefore, the understanding on these interactions and the binding kinetics of target molecules plays an important role in the drug discovery for various chronic diseases.

The label free detection technologies support researchers for accurate identification of basic mechanism of biomolecules and target assay in chronic diseases; thereby enabled the researchers in innovating new drug discovery programs. In addition, this eliminates the risk of most of the molecular and genetic diseases by pre-clinical detection, thereby increasing the adoption of label free detection technologies in research activities across the globe.

Market Dynamics

Drivers

• Rapid Growth in Pharmaceutical and Biotechnology Market
• Rising Government Initiatives and Funding For various R&D activities
• Increasing Adoption of Innovative Approaches in Drug Discovery

Restraints

• High Cost of Instruments
• Shortage of Skilled Professionals to Handle Complex Equipment

Opportunities

• Emerging Economies: Asia Pacific and Latin America

Scope of the report

Market by Product

• Consumables
• Biosensor chips
• Microplates
• Instruments

Market by Technology

• Surface Plasmon Resonance
• Bio-Layer Interferometry
• Cellular Dielectric Spectroscopy
• Electrical Impedance Spectroscopy
• Optical Waveguide Grating Technology
• Others

Market by Application

• Binding Kinetics
• Hit Confirmation
• Lead Generation
• Endogenous Receptor Detection
• Binding Thermodynamics
• Others

Market by End Users

• Pharmaceutical and Biotechnology Industry
• Academic and Research Institutes
• Contract Research Organizations
• Others
  

Companies Mentioned

• AMETEK, Inc.
• Attana AB
• BiOptix Inc.
• Bio-Rad Laboratories, Inc.
• BioNavis Limited
• Corning Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Horiba, Ltd.
• PerkinElmer Inc.

For more information about this report visit https://www.researchandmarkets.com/research/rvm7xc/labelfree

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets